"Publicly available data should be treated as open data, a shared resource with unrestricted use for analysis, interpretation, and publication." --The journal Science report on genomic data … [Read more...]
CAPITAL
Investment Trends: Dx/Tools Venture Capital Keeps Flowing Despite Decline in Early-Stage Investment
February 5, 2019
Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of $9.6 billion, according to Silicon Valley Bank's (SVB) Trends in … [Read more...]
SPECIAL FOCUS
Evidence Building for Use of Liquid Biopsy to Drive Treatment Decisions, Monitor Disease Activity
December 31, 2018
Emerging evidence shows that liquid biopsy is a viable option for detecting and monitoring genomic mutations to inform treatment decisions and to assess disease activity in real-world clinical … [Read more...]
WALL STREET JOURNAL WRITER
Carreyrou Captivates Lab Institute With Inside Look at Theranos Fall
October 25, 2018
The tale could be headed to movie theaters around the nation soon. It is a gripping story of a Steve Jobs-wannabe—a young Stanford dropout with a vision and more than $400 million in funding from … [Read more...]
RESEARCH
Genomics Giants Accused of Misappropriating Sequencing Technology
October 5, 2018
Case: A trio of medical researchers are accusing Illumina, Thermo Fisher Scientific and Affymetrix of stealing the zip code sequencing technology they developed. The trade secret theft and fraud … [Read more...]
MARKET TRENDS
By the Numbers: Spike in M.D. Practice Acquisitions Drives Up Costs of Hospital Care
April 16, 2018
Hospitals are gobbling up M.D. practices at a record rate. In addition to endangering the independent physician practice, this trend is driving up the costs of hospital care by adding ever higher … [Read more...]
PUBLIC HEALTH
Influenza Testing: Study Finds Older Patients Are Under-Tested and Under-Diagnosed
February 27, 2018
The worst flu season in years adds immediacy to a new study tracking flu test utilization patterns based on age. The key finding: Older adults hospitalized with fever or respiratory symptoms during … [Read more...]
RESEARCH
The Year in Dx VC Investment: Dx/Tools Outperforms Health Care & Liquid Biopsy/AI/ Informatics Outperforms Dx/Tools
February 7, 2018
In a year that witnessed venture capital health care investment reaching an all-time high, diagnostics/tools (Dx/Tools) companies made out particularly well, according to Silicon Valley Banks' … [Read more...]
INDUSTRY BUZZ
Genetic Profiling: Study Casts Doubt on Cost-Effectiveness of Leading Breast Cancer Recurrence Assay
January 29, 2018
Among the many genetic profiling assays entering the commercial market, few have been more successful than Genomic Heath's Oncotype DX, which is now covered by most of the nation's biggest insurers. … [Read more...]
CAPITAL
Industry Trends: New Report Sheds Light on DX Tech Capital Flows
October 10, 2017
The health care industry has raised $5 billion in venture fund investment in the first half of 2017 and is well on pace to smash the single year record of $7.5 billion set in 2015, according to … [Read more...]
